Torrent Pharmaceuticals Limited (BOM: 500420)
India
· Delayed Price · Currency is INR 3,426.05
-0.75 (-0.02%)
At close: Sep 10, 2024
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 28.59B INR in the quarter ending June 30, 2024, with 10.34% growth. This brings the company's revenue in the last twelve months to 109.96B, up 11.47% year-over-year. In the fiscal year ending March 31, 2024, Torrent Pharmaceuticals had annual revenue of 107.28B with 11.51% growth.
Revenue (ttm)
109.96B
Revenue Growth
+11.47%
P/S Ratio
10.55
Revenue / Employee
7.00M
Employees
15,718
Market Cap
1,159.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
| Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
| Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
| Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
| Mar 31, 2020 | 79.39B | 2.67B | 3.47% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTorrent Pharmaceuticals News
- 12 days ago - Torrent Pharma shares surge around 2% after USFDA inspection closure - Business Upturn
- 12 days ago - Torrent Pharma’s Indrad facility receives USFDA EIR with VAI Classification - Business Upturn
- 4 weeks ago - Torrent Is Said to Seek Raising $3 Billion for KKR’s Stake in JB - BNN Bloomberg